265 related articles for article (PubMed ID: 12860165)
1. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
[TBL] [Abstract][Full Text] [Related]
2. Histologic findings in patients with head and neck squamous cell carcinoma receiving perilymphatic natural cytokine mixture (IRX-2) prior to surgery.
Meneses A; Verastegui E; Barrera JL; Zinser J; de la Garza J; Hadden JW
Arch Pathol Lab Med; 1998 May; 122(5):447-54. PubMed ID: 9593347
[TBL] [Abstract][Full Text] [Related]
3. A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck.
Hadden J; Verastegui E; Barrera JL; Kurman M; Meneses A; Zinser JW; de la Garza J; Hadden E
Int Immunopharmacol; 2003 Aug; 3(8):1073-81. PubMed ID: 12860164
[TBL] [Abstract][Full Text] [Related]
4. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
7. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.
Verastegui E; Barrera JL; Zinser J; Del Rio R; Meneses A; De La Garza J; Hadden JW
Int J Immunopharmacol; 1997; 19(11-12):619-27. PubMed ID: 9669202
[TBL] [Abstract][Full Text] [Related]
8. The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical Trial.
Tímár J; Forster-Horváth C; Lukits J; Döme B; Ladányi A; Remenár E; Kásler M; Bencsik M; Répássy G; Szabó G; Velich N; Suba Z; Elõ J; Balatoni Z; Bajtai A; Chretien P; Talor E
Laryngoscope; 2003 Dec; 113(12):2206-17. PubMed ID: 14660929
[TBL] [Abstract][Full Text] [Related]
9. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?
McHam SA; Adelstein DJ; Rybicki LA; Lavertu P; Esclamado RM; Wood BG; Strome M; Carroll MA
Head Neck; 2003 Oct; 25(10):791-8. PubMed ID: 12966502
[TBL] [Abstract][Full Text] [Related]
10. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
[TBL] [Abstract][Full Text] [Related]
11. Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.
Barrera JL; Verastegui E; Meneses A; Zinser J; de la Garza J; Hadden JW
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):345-51. PubMed ID: 10722007
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
[TBL] [Abstract][Full Text] [Related]
13. A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
Freeman SM; Franco JL; Kenady DE; Baltzer L; Roth Z; Brandwein HJ; Hadden JW
Am J Clin Oncol; 2011 Apr; 34(2):173-8. PubMed ID: 20539208
[TBL] [Abstract][Full Text] [Related]
14. Immunodeficiency and cancer: prospects for correction.
Hadden JW
Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163
[TBL] [Abstract][Full Text] [Related]
15. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Argiris A; Stenson KM; Brockstein BE; Mittal BB; Pelzer H; Kies MS; Jayaram P; Portugal L; Wenig BL; Rosen FR; Haraf DJ; Vokes EE
Head Neck; 2004 May; 26(5):447-55. PubMed ID: 15122662
[TBL] [Abstract][Full Text] [Related]
16. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
17. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
[TBL] [Abstract][Full Text] [Related]
18. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
Saxon A; Portis J
Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
[TBL] [Abstract][Full Text] [Related]
19. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
Faustina M; Diba R; Ahmadi MA; Esmaeli B
Ophthalmology; 2004 Oct; 111(10):1930-2. PubMed ID: 15465559
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]